2014
DOI: 10.1371/journal.pone.0085678
|View full text |Cite
|
Sign up to set email alerts
|

istar: A Web Platform for Large-Scale Protein-Ligand Docking

Abstract: Protein-ligand docking is a key computational method in the design of starting points for the drug discovery process. We are motivated by the desire to automate large-scale docking using our popular docking engine idock and thus have developed a publicly-accessible web platform called istar. Without tedious software installation, users can submit jobs using our website. Our istar website supports 1) filtering ligands by desired molecular properties and previewing the number of ligands to dock, 2) monitoring jo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
110
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 102 publications
(111 citation statements)
references
References 43 publications
1
110
0
Order By: Relevance
“…The free and open‐source docking software idock v2.2.1 was executed to predict the binding conformations and the binding affinities of the 3,167 compounds upon docking against the FGFR3 structure. Program settings were tuned to make the conformational searching procedure more exhaustive than the default settings.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The free and open‐source docking software idock v2.2.1 was executed to predict the binding conformations and the binding affinities of the 3,167 compounds upon docking against the FGFR3 structure. Program settings were tuned to make the conformational searching procedure more exhaustive than the default settings.…”
Section: Methodsmentioning
confidence: 99%
“…We used the free and open‐source protein–ligand docking software idock together with the binding affinity prediction software RF‐Score‐v3 to virtually screen and rank worldwide approved small‐molecule drugs (including but not limited to those approved by US FDA) with potential ability to inhibit FGFR3, and then used the molecular visualization tool iview to inspect and analyze putative interactions. Among the high‐scoring compounds shortlisted computationally, six were purchased for experimental validation in vitro in BC cell lines RT112 and RT4 via cell viability assays, cell apoptosis assays, Western blotting and immunoprecipitation experiments.…”
Section: Introductionmentioning
confidence: 99%
“…Now because this study focuses on co-crystallized ligands, there is only one conformer per molecule (k=1) and thus the intramolecular contribution cancels out giving: [9] for an explanation of how this conversion factor is derived). The values for the six weights were found by minimising the difference between predicted and measured binding affinity using a nonlinear optimisation algorithm (this process was not detailed in the original publication [13]).…”
Section: Model 1 -Autodock Vinamentioning
confidence: 99%
“…RF-Score has recently been used [2] to discover a large number of innovative binders of antibacterial targets. This machine-learning scoring function has now been incorporated [9] into a large-scale docking tool for prospective virtual screening, which is freely available at http://istar.cse.cuhk.edu.hk/idock/. There is also a recent version of RF-Score [1] incorporating interatomic distance-dependent features to improve the characterization of the complex.…”
Section: Introductionmentioning
confidence: 99%
“…In practice, most of the generalized receptor-based machine-learning scoring functions described in the literature have not been publically released, and so are mere proofs of concept. To our knowledge, only NNScore 1.0 (26), NNScore 2.0 (27), and RF-Score (52, 59) are publically available. Nevertheless, though still in its infancy, the application of machine learning to antibiotic research specifically, and drug design generally, clearly has a bright future.…”
Section: Future Directionsmentioning
confidence: 99%